FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approves Hikma Pharmaceuticals USA Inc.'s supplemental application for ALENDRONATE SODIUM, indicating an approved change under the ANDA process.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

SUPPL AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)